Advisers 'looking very carefully' at Johnson & Johnson jab amid blood clot fears
Regulators in the UK said that they will examine ‘any safety reports’ during their considerations on whether or not to approve the jab.
Stay updated with breaking news from Technology Commitee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regulators in the UK said that they will examine ‘any safety reports’ during their considerations on whether or not to approve the jab.
Britain is still on track to offer a Covid-19 vaccine to all UK adults by the end of July – despite a pause in the rollout of the Janssen vaccine in Europe, officials have confirmed. The UK has 30 million doses of the inoculation on order, but it has not yet been signed off for use by the Medicines and Healthcare products Regulatory Agency (MHRA). The doses are expected to arrive in the second half of 2021 if approved by the regulator. But the Department of Health and Social Care (DHSC) insisted Johnson & Johnson’s decision to delay the rollout of its vaccine in Europe would not derail th...
Regulators in the UK said that they will examine ‘any safety reports’ during their considerations on whether or not to approve the jab.
Regulators in the UK said that they will examine ‘any safety reports’ during their considerations on whether or not to approve the jab.
Nadhim Zahawi said there would be a ‘big uplift in supply’ expected before the end of the month.